Study of Jaktinib Hydrochloride Tablets in Participants With Idiopathic Pulmonary Fibrosis

NCT04312594 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Jaktinib Hydrochloride Tablets
DRUG: Jaktinib Hydrochloride Tablets
DRUG: Placebo

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd